Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
07 May 2019Website:
http://www.trevitherapeutics.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Tue, 02 Jul 2024 20:02:23 GMTDividend
Analysts recommendations
Institutional Ownership
TRVI Latest News
Trevi Therapeutics (TRVI) seems to have stabilized after a recent decline, with the formation of a hammer chart suggesting potential support. Along with this technical indicator, increased consensus among analysts in raising earnings forecasts could contribute to a possible rebound for the stock in the near future.
Trevi Therapeutics (TRVI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Trevi Therapeutics, Inc. (TRVI) Q4 2023 Earnings Call Transcript
Trevi Therapeutics, Inc. (TRVI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
The heavy selling pressure might have exhausted for Trevi Therapeutics, Inc. (TRVI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
The heavy selling pressure might have exhausted for Trevi Therapeutics, Inc. (TRVI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Trevi Therapeutics, Inc. (NASDAQ:TRVI ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Jennifer Good - President and Chief Executive Officer Lisa Delfini - Chief Financial Officer David Clark - Chief Medical Officer Conference Call Participants Annabel Samimy - Stifel Rohan Mathur - Oppenheimer Sean Kim - JonesTrading Serge Belanger - Needham & Company Mayank Mamtani - B. Riley Securities Operator Good afternoon and welcome to the Trevi Therapeutics Q3 2023 Earnings Conference Call.
Trevi Therapeutics, Inc. (TRVI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Trevi Therapeutics, Inc. (NASDAQ:TRVI ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Jennifer Good - President and Chief Executive Officer Lisa Delfini - Chief Financial Officer Conference Call Participants Annabel Samimy - Stifel Serge Belanger - Needham and Company Leland Gershell - Oppenheimer William Wood - B. Riley Securities Operator Good afternoon and welcome to the Trevi Therapeutics' Second Quarter 2023 Earnings Conference Call.
What type of business is Trevi Therapeutics?
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
What sector is Trevi Therapeutics in?
Trevi Therapeutics is in the Healthcare sector
What industry is Trevi Therapeutics in?
Trevi Therapeutics is in the Biotechnology industry
What country is Trevi Therapeutics from?
Trevi Therapeutics is headquartered in United States
When did Trevi Therapeutics go public?
Trevi Therapeutics initial public offering (IPO) was on 07 May 2019
What is Trevi Therapeutics website?
https://www.trevitherapeutics.com
Is Trevi Therapeutics in the S&P 500?
No, Trevi Therapeutics is not included in the S&P 500 index
Is Trevi Therapeutics in the NASDAQ 100?
No, Trevi Therapeutics is not included in the NASDAQ 100 index
Is Trevi Therapeutics in the Dow Jones?
No, Trevi Therapeutics is not included in the Dow Jones index
When does Trevi Therapeutics report earnings?
The next expected earnings date for Trevi Therapeutics is 09 August 2024